Asia-Pacific Glucagon-Like Peptide 1 (GLP-1) Agonists Market Insight The Asia-Pacific Glucagon-Like Peptide 1 (GLP-1) Agonists market is expected to witness rapid growth and is projected to register the fastest CAGR of 9.4% from 2026 to 2033 , driven by the rapidly expanding diabetic population, rising obesity prevalence, and increasing healthcare expenditure across countries such as China, India, Japan, and South Korea
Furthermore, Doxorubicin and Cyclophosphamide reduced synaptic plasticity via hindering expression of brain-derived neurotrophic factor, phosphorylated cyclase response element binding protein, synaptophysin, and postsynaptic density protein 95 whereas protein expression of such synaptic plasticity biomarkers was enhanced by L-carnitine treatment
During these procedures, surgeons employ various stabilization techniques, including the installation of plates, screws, or wires to secure the fractured bones
While these findings do not establish diagnostic biomarkers, they underscore the relevance of metabolic profiling in ASD and support further investigation into dietary strategies as adjunctive, individualized interventions
Plants 2020;9
Most of the distinct microbial features could still be identified in top 17 rankings ( Supplementary Figure 6 )